UNSPSC 51241219: Tazarotene

This classification denotes a retinoic acid agent with the molecular formula C21H21NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81BDR9Y8PS, chemically known as 3-pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2h-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester but generally known as tazarotene, which bears US NIH Compound Identifier 5381. European Medicines Agency schedules Tazarotene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10844MIG.

UNSPSC 51241219 Tazarotene is a Commodity code that appears to track pharmaceutical topical treatments, but the recent state and local opportunities posted under this code show no alignment with tazarotene procurement. The two opportunities in the recent record are unrelated to the code's nominal scope: one solicits liquid aluminum sulfate for wastewater treatment, and the other solicits medical aid supplies and first aid consumables for fire rescue operations. State and local procurement databases occasionally misclassify opportunities by UNSPSC code, and this code shows little or no relevant recent activity in municipal or county purchasing. Without concrete recent opportunities actually buying tazarotene at the state and local level, the code does not support actionable business development guidance at this time.

The mismatch between the code name and the posted opportunities signals either a data-quality issue in the underlying procurement system or the absence of meaningful state and local demand for tazarotene products under this classification. Firms pursuing opportunities under this code should verify current activity through direct outreach to state pharmacy procurement offices, Medicaid managed care programs, and corrections departments, which are typical end users of topical pharmaceuticals in the public sector, rather than relying on recent posting volume under this specific UNSPSC number.